A simple algebraic approximation to the Erlang loss systemADELMAN, Daniel.Operations research letters. 2008, Vol 36, Num 4, pp 484-491, issn 0167-6377, 8 p.Article

Price-Directed Control of a Closed Logistics Queueing NetworkADELMAN, Daniel.Operations research. 2007, Vol 55, Num 6, pp 1022-1038, issn 0030-364X, 17 p.Article

Existence of optimal policies for semi-Markov decision processes using duality for infinite linear programmingKLABJAN, Diego; ADELMAN, Daniel.SIAM journal on control and optimization. 2006, Vol 44, Num 6, pp 2104-2122, issn 0363-0129, 19 p.Article

Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapyCORREN, Jonathan; SHAPIRO, Gail; REIMANN, James et al.Journal of allergy and clinical immunology. 2008, Vol 121, Num 2, pp 506-511, issn 0091-6749, 6 p.Article

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisCORREN, Jonathan; DIAZ-SANCHEZ, David; SAXON, Andrew et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 3, pp 243-248, issn 1081-1206, 6 p.Article

Photodynamic therapy: Applications in atherosclerotic vascular disease with motexafin lutetiumCHOU, Tony M; WOODBURN, Kathryn W; CHEONG, Wai-Fung et al.Catheterization and cardiovascular interventions. 2002, Vol 57, Num 3, pp 387-394, issn 1522-1946, 8 p.Article

Photoangioplasty for human peripheral atherosclerosis: Results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)ROCKSON, Stanley G; KRAMER, Paul; ADELMAN, Daniel C et al.Circulation (New York, N.Y.). 2000, Vol 102, Num 19, pp 2322-2324, issn 0009-7322Article

Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: Procedural and long-term resultsKEREIAKES, Dean J; SZYNISZEWSKI, Arthur M; CHOU, Tony M et al.Circulation (New York, N.Y.). 2003, Vol 108, Num 11, pp 1310-1315, issn 0009-7322, 6 p.Article